Synthomer (SYNT) Receives Underweight Rating from JPMorgan Chase & Co.

JPMorgan Chase & Co. restated their underweight rating on shares of Synthomer (LON:SYNT) in a research report report published on Wednesday morning.

SYNT has been the subject of a number of other research reports. Peel Hunt reaffirmed a buy rating on shares of Synthomer in a report on Monday, November 5th. UBS Group reaffirmed a sell rating and set a GBX 370 ($4.83) target price (down previously from GBX 440 ($5.75)) on shares of Synthomer in a report on Thursday, October 25th. Canaccord Genuity reaffirmed a buy rating and set a GBX 575 ($7.51) target price on shares of Synthomer in a report on Monday, October 29th. Numis Securities raised Synthomer to an add rating in a report on Tuesday, August 7th. Finally, Deutsche Bank lifted their target price on Synthomer from GBX 640 ($8.36) to GBX 645 ($8.43) and gave the stock a buy rating in a report on Tuesday, October 2nd. Two research analysts have rated the stock with a sell rating, one has given a hold rating and five have given a buy rating to the company’s stock. The company currently has an average rating of Hold and an average price target of GBX 541.88 ($7.08).

Shares of Synthomer stock traded down GBX 5.20 ($0.07) on Wednesday, reaching GBX 453.40 ($5.92). 397,269 shares of the stock were exchanged, compared to its average volume of 523,513. Synthomer has a twelve month low of GBX 452.51 ($5.91) and a twelve month high of GBX 517.50 ($6.76).

Synthomer Company Profile

Synthomer plc operates as a specialty chemical company in Europe, North America, Asia, and internationally. It offers adhesives for use in labels, graphics, specialty tapes, caulks and sealants, wet glues, protective films, packaging, and other applications; and high solid lattices for foamed footwear and bedding products.

Read More: Outstanding Shares, Buying and Selling Stocks

Analyst Recommendations for Synthomer (LON:SYNT)

Receive News & Ratings for Synthomer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synthomer and related companies with's FREE daily email newsletter.

Leave a Reply